Penzberg, Germany

Jens Christian Bolle


Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
3 patents (USPTO):

Title: **Innovative Contributions of Inventor Jens Christian Bolle**

Introduction

Jens Christian Bolle, an accomplished inventor based in Penzberg, Germany, has made significant strides in the field of molecular biology. With a focus on magnetic nanoparticles, he has contributed to the advancement of nucleic acid purification technologies. His expertise and innovations have been recognized through the granting of three patents.

Latest Patents

Bolle's most recent patents demonstrate his commitment to enhancing nucleic acid purification processes. The first patent, titled "Magnetic nanoparticles for nucleic acid purification," involves monodisperse silanized ferrimagnetic iron oxide particles, along with methods for their production and independent generic binding of nucleic acid molecules to these particles. The second patent, "Synthesis of magnetic nanoparticles for nucleic acid purification," relates to similar technologies, emphasizing his focus on developing effective and efficient methods for researchers.

Career Highlights

Jens Christian Bolle is currently employed at Roche Molecular Systems, Inc., where he continues his work on innovative solutions in molecular diagnostics. His role at Roche highlights his contribution to the life sciences industry, where his patents are being positioned to enhance laboratory efficiencies and improve research outcomes.

Collaborations

Throughout his career, Bolle has collaborated with notable colleagues, including Thomas Walter and Peter Wenzig. Their collaborative efforts have likely fostered a creative environment, leading to innovative applications of their research in practical settings.

Conclusion

Jens Christian Bolle's contributions to the field of nucleic acid purification through his patented inventions reflect his dedication to scientific advancement. As he continues to work with Roche Molecular Systems, his innovations are poised to make a lasting impact on molecular biology, benefitting both research institutions and the broader scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…